Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$38,998,263
+$5,429,055 QoQ
Shares Held
2,886,622
+7.1% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FIL Ltd holds $820,100,378 across 8 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,487,134 | $648,634,110 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,694,634 | $111,282,375 | |
| 3 | VTRS |
Viatris Inc
This page
|
2,886,622 | $38,998,263 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
216,669 | $16,434,343 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
84,619 | $2,024,932 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
3,021 | $1,791,392 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
6,752 | $889,508 | |
| 8 | HLN |
Haleon plc
|
4,541 | $45,455 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38,998,263 | 2,886,622 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $33,569,208 | 2,696,322 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $25,714,279 | 2,597,402 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $43,949,182 | 4,921,521 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $51,537,923 | 5,917,098 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $77,694,586 | 6,240,529 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $69,197,271 | 5,960,144 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $57,977,890 | 5,454,176 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $50,760,748 | 4,251,319 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $35,903,106 | 3,315,153 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $23,291,015 | 2,362,172 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $18,919,016 | 1,895,693 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $19,255,440 | 2,001,605 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $5,403,080 | 485,452 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,750,818 | 322,866 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,211,536 | 115,715 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,263,200 | 116,103 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,657,426 | 196,410 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,897,260 | 213,820 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $59,893,661 | 4,191,299 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $70,201,358 | 5,025,151 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $204,085,439 | 10,890,365 | Shares | Defined | 2021-03-23 | |
| No filing history on record for this holder in this stock. | ||||||